Y-Intercept (Hong Kong) Ltd - ADMA BIOLOGICS INC ownership

ADMA BIOLOGICS INC's ticker is ADMA and the CUSIP is 000899104. A total of 75 filers reported holding ADMA BIOLOGICS INC in Q3 2021. The put-call ratio across all filers is 4.90 and the average weighting 0.0%.

Quarter-by-quarter ownership
Y-Intercept (Hong Kong) Ltd ownership history of ADMA BIOLOGICS INC
ValueSharesWeighting
Q2 2023$70,863
-19.5%
19,204
-60.3%
0.01%
-65.0%
Q1 2022$88,000
+225.9%
48,328
+190.2%
0.02%
+185.7%
Q2 2021$27,00016,6560.01%
Other shareholders
ADMA BIOLOGICS INC shareholders Q3 2021
NameSharesValueWeighting ↓
Velan Capital Investment Management LP 4,000,000$13,240,00011.29%
Stonepine Capital Management, LLC 7,661,690$25,360,1948.50%
Altium Capital Management LP 2,870,000$9,499,7005.27%
Caligan Partners LP 1,662,613$5,503,2493.84%
AWM Investment Company, Inc. 6,015,000$19,909,6502.69%
Perceptive Advisors 11,900,255$39,389,8441.16%
EAM Investors, LLC 1,035,752$3,428,3390.67%
OBERWEIS ASSET MANAGEMENT INC/ 1,169,500$3,871,0450.60%
Magnetar Financial LLC 7,074,722$23,417,3300.46%
Virtus ETF Advisers LLC 83,925$277,7920.15%
View complete list of ADMA BIOLOGICS INC shareholders